Virtual tissue staining by deep learning
Develop a virtual tissue-staining device using optics and deep learning to replace manual staining, enhancing accessibility and efficiency in biomedical research.
Projectdetails
Introduction
Our goal is to create a virtual tissue-staining device to replace manual chemical-staining techniques by integrating optics and deep learning.
Importance of Chemical Staining
Chemical staining of cell components plays an essential role in biomedical and pharmaceutical research and practice.
Cell structures of interest are highlighted using various chemical stains and imaged with the appropriate optical setup. However, these techniques are often invasive and sometimes even toxic to the cells. In addition, they are:
- Time-consuming
- Labor-intensive
- Expensive
Deep Learning as a Solution
Recently, the use of deep learning has been proposed as a way to create images of virtually stained cell structures, thus mitigating the inherent problems associated with conventional chemical staining.
However, these methods are usually specialized for a specific application and, thus, highly dependent on the setting of the optical device used for acquiring the training data.
Proposed Device
In order to make virtual tissue-staining more accessible to end-users, we propose a device based on a simple optical system with integrated deep-learning-powered virtual-staining software.
Market Opportunity
This is an ideal moment to enter the virtual tissue-staining market because we can gain a first mover advantage.
Further, we can take advantage of the fact that the tissue-staining market is expected to grow with a compound annual growth rate of roughly 8.5% until 2025 (up to 3400M USD), and to continue to grow for the foreseeable future.
Startup Launch
As part of this project, we aim to launch the startup company IFLAI to commercially exploit our virtual-staining technology and the prototype we will develop.
With the startup IFLAI, we aim to provide approximately 20 jobs to university-educated individuals in the EU within the next 5 years. IFLAI has already received initial funding and support from two different organizations that support and believe in its venture.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 31-10-2024 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- GOETEBORGS UNIVERSITETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Non-invasive computational immunohistochemical staining based on deep learning and multimodal imagingSTAIN-IT aims to develop a fast, non-invasive, label-free immunohistochemical staining method using multimodal imaging and deep learning to enhance cancer diagnosis and understanding of disease pathogenesis. | ERC Consolid... | € 1.989.086 | 2023 | Details |
Deep Label-Free Cell Imaging of Liquid Biopsies for Cancer MonitoringDevelop and commercialize a label-free interferometric phase microscopy device with AI for cost-effective cancer diagnosis and monitoring via liquid biopsies. | ERC Proof of... | € 150.000 | 2023 | Details |
Advanced X-ray Energy-sensitive Microscopy for Virtual HistologyThis project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Live imaging module for organoidsThe LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields. | ERC Proof of... | € 150.000 | 2024 | Details |
Development of a nanobody-based, slide-free approach for 3D-Histological analysis of the spatial tumor microenvironment using lightsheet imagingThis project aims to revolutionize cancer histology through a nanobody-based 3D-histopathology approach, enabling rapid, spatially accurate analysis of tumor microenvironments for improved diagnosis and patient stratification. | ERC Proof of... | € 150.000 | 2025 | Details |
Non-invasive computational immunohistochemical staining based on deep learning and multimodal imaging
STAIN-IT aims to develop a fast, non-invasive, label-free immunohistochemical staining method using multimodal imaging and deep learning to enhance cancer diagnosis and understanding of disease pathogenesis.
Deep Label-Free Cell Imaging of Liquid Biopsies for Cancer Monitoring
Develop and commercialize a label-free interferometric phase microscopy device with AI for cost-effective cancer diagnosis and monitoring via liquid biopsies.
Advanced X-ray Energy-sensitive Microscopy for Virtual Histology
This project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions.
Live imaging module for organoids
The LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields.
Development of a nanobody-based, slide-free approach for 3D-Histological analysis of the spatial tumor microenvironment using lightsheet imaging
This project aims to revolutionize cancer histology through a nanobody-based 3D-histopathology approach, enabling rapid, spatially accurate analysis of tumor microenvironments for improved diagnosis and patient stratification.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
EndocartoScope: Transforming any Endoscope into a Smart Device for Intraoperative 3D Localization, Navigation and MappingEndoCartoScope aims to develop a real-time 3D mapping system for endoscopy using VSLAM technology, enhancing navigation and measurement for improved diagnostics and future robotic applications. | EIC Transition | € 2.498.425 | 2025 | Details |
Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell CultureThe Vasc-on-Demand project aims to develop three innovative products for easy generation of vascularized 3D tissues, enhancing research and drug testing while reducing reliance on animal trials. | EIC Transition | € 2.488.750 | 2024 | Details |
Haalbaarheidsonderzoek Virtuele Anatomie DocentVIEMR onderzoekt de haalbaarheid van een AI-gestuurde Virtuele Anatomie Docent om interactieve digitale leermethoden te ontwikkelen voor medische studenten, ter aanvulling van het Enatom platform. | Mkb-innovati... | € 20.000 | 2022 | Details |
Enabling the transition to 3D digital pathology3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally. | EIC Transition | € 2.493.683 | 2025 | Details |
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to LabBiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening. | EIC Transition | € 2.500.000 | 2022 | Details |
EndocartoScope: Transforming any Endoscope into a Smart Device for Intraoperative 3D Localization, Navigation and Mapping
EndoCartoScope aims to develop a real-time 3D mapping system for endoscopy using VSLAM technology, enhancing navigation and measurement for improved diagnostics and future robotic applications.
Prefabricated Mature Blood Vessels and Tools for Vascularized 3D Cell Culture
The Vasc-on-Demand project aims to develop three innovative products for easy generation of vascularized 3D tissues, enhancing research and drug testing while reducing reliance on animal trials.
Haalbaarheidsonderzoek Virtuele Anatomie Docent
VIEMR onderzoekt de haalbaarheid van een AI-gestuurde Virtuele Anatomie Docent om interactieve digitale leermethoden te ontwikkelen voor medische studenten, ter aanvulling van het Enatom platform.
Enabling the transition to 3D digital pathology
3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.
Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to Lab
BiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening.